113 related articles for article (PubMed ID: 409748)
1. Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.
Fogelman I; Greig WR; Bessent RG; Boyle IT
J Nucl Med; 1977 Oct; 18(10):1040-1. PubMed ID: 409748
[No Abstract] [Full Text] [Related]
2. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
4. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
5. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
Martin W; Fogelman I; Bessent RG
J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m diphosphonate retention in hyperparathyroidism.
Heath H
Ann Intern Med; 1980 Jun; 92(6):873-4. PubMed ID: 7387037
[No Abstract] [Full Text] [Related]
8. In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography.
Pinkerton TC; Ferguson DL; Deutsch E; Heineman WR; Libson K
Int J Appl Radiat Isot; 1982 Oct; 33(10):907-15. PubMed ID: 6818160
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
Watt I; Hill P
Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
[TBL] [Abstract][Full Text] [Related]
10. Influence of complex charge and size on the uptake of 99mTc-diphosphonates in osteogenic tissue.
Pinkerton TC; Cheng KT; Shaw SM; Wilson GM
Int J Rad Appl Instrum B; 1986; 13(1):49-56. PubMed ID: 3095270
[TBL] [Abstract][Full Text] [Related]
11. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate.
Fogelman I; Bessent RG; Beastall G; Boyle IT
Ann Intern Med; 1980 Jan; 92(1):65-7. PubMed ID: 6766051
[No Abstract] [Full Text] [Related]
12. Case report: intravenous etidronate as a cause of poor uptake on bone scanning, with a review of the literature.
Chong WK; Cunningham DA
Clin Radiol; 1991 Oct; 44(4):268-70. PubMed ID: 1835685
[TBL] [Abstract][Full Text] [Related]
13. Measurements of the distribution of technetium-99m sulfur colloid and technetium-99m HEDP in normal humans.
Grossman LW; Sodd VJ; Nishiyama H; Feller PA; Hoops RG
Med Phys; 1983; 10(1):79-82. PubMed ID: 6405144
[TBL] [Abstract][Full Text] [Related]
14. Bone scintigraphy in renal osteodystrophy.
de Graaf P; Schicht IM; Pauwels EK; te Velde J; de Graeff J
J Nucl Med; 1978 Dec; 19(12):1289-96. PubMed ID: 104017
[TBL] [Abstract][Full Text] [Related]
15. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.
Smith ML; Martin W; Fogelman I; Bessent RG
J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571
[TBL] [Abstract][Full Text] [Related]
16. A quantitative evaluation of rheumatoid arthritic activity with Tc-99m HEDP.
Park HM; Terman SA; Ridolfo AS; Wellman HN
J Nucl Med; 1977 Oct; 18(10):973-6. PubMed ID: 409749
[TBL] [Abstract][Full Text] [Related]
17. Binding of the bone-seeking agent 99mTc-1-hydroxyethylidene-1,1-diphosphonic acid to cartilage and collagen in vitro and its stimulation by Er3+ and low pH.
Evans CH; Mears DC
Calcif Tissue Int; 1980; 32(2):91-4. PubMed ID: 6773636
[TBL] [Abstract][Full Text] [Related]
18. [A comparison of osteotropic radiopharmaceuticals. II. Plasma clearance of 18F and 99mTc-EHDP (author's transl)].
Creutzig H
Rofo; 1975 Oct; 123(4):313-8. PubMed ID: 129388
[TBL] [Abstract][Full Text] [Related]
19. Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumors.
Citrin DL; Bessent RG; McGinley E; Gordon D
J Nucl Med; 1975 Oct; 16(10):886-90. PubMed ID: 809552
[TBL] [Abstract][Full Text] [Related]
20. What do we want from a bone-scanning agent?
Fogelman I; Bessent RG
J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
